The macroenzymes: A clinical review

P. J. Galasso, S. C. Litin, J. F. O'Brien

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

Macroenzymes are serum enzymes that have a higher molecular mass than the corresponding enzyme normally found in serum under physiologic or pathophysiologic conditions. Although no evidence convincingly indicates that macroenzymes cause disease or necessitate treatment, some patients with immunoglobulin-complexed enzyme disorders have previously been reported to have associated autoimmune diseases or malignant lesions. To address this issue, we reviewed the medical records of 42 patients in whom a macroenzyme had been detected during assessment at the Mayo Clinic between 1986 and 1990. Of these 42 patients, 21 had macro-creatine kinase, 10 had macro-lactate dehydrogenase, 6 had macro-aspartate aminotransferase, and 5 had macroamylase in the serum. Although the study group did not include all Mayo patients with this phenomenon, it represented a sufficient sample size to determine retrospectively whether specific dismissal diagnoses were present concurrently. The most common findings in this group of patients with macroenzymes were (1) advanced age (except for those with macro-aspartate aminotransferase), (2) cardiovascular disease (probably due to sampling bias), (3) malignant lesions (particularly in those with macro-creatine kinase), and (4) rheumatologic disease (in those with macro-lactate dehydrogenase). The immunoglobulin-complexed enzyme disorders are characterized by increased total serum enzyme levels that are often isolated and persistent. Physicians should be aware of the presence of macroenzymes so that invasive or costly procedures are not undertaken unnecessarily to determine the cause of increased serum enzyme levels.

Original languageEnglish (US)
Pages (from-to)349-354
Number of pages6
JournalMayo Clinic Proceedings
Volume68
Issue number4
StatePublished - 1993

Fingerprint

Enzymes
Serum
Creatine Kinase
Aspartate Aminotransferases
L-Lactate Dehydrogenase
Immunoglobulins
Selection Bias
Sample Size
Autoimmune Diseases
Medical Records
Cardiovascular Diseases
Physicians
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Galasso, P. J., Litin, S. C., & O'Brien, J. F. (1993). The macroenzymes: A clinical review. Mayo Clinic Proceedings, 68(4), 349-354.

The macroenzymes : A clinical review. / Galasso, P. J.; Litin, S. C.; O'Brien, J. F.

In: Mayo Clinic Proceedings, Vol. 68, No. 4, 1993, p. 349-354.

Research output: Contribution to journalArticle

Galasso, PJ, Litin, SC & O'Brien, JF 1993, 'The macroenzymes: A clinical review', Mayo Clinic Proceedings, vol. 68, no. 4, pp. 349-354.
Galasso PJ, Litin SC, O'Brien JF. The macroenzymes: A clinical review. Mayo Clinic Proceedings. 1993;68(4):349-354.
Galasso, P. J. ; Litin, S. C. ; O'Brien, J. F. / The macroenzymes : A clinical review. In: Mayo Clinic Proceedings. 1993 ; Vol. 68, No. 4. pp. 349-354.
@article{dc1615d6ea0c47858a59b2da5b66d2e2,
title = "The macroenzymes: A clinical review",
abstract = "Macroenzymes are serum enzymes that have a higher molecular mass than the corresponding enzyme normally found in serum under physiologic or pathophysiologic conditions. Although no evidence convincingly indicates that macroenzymes cause disease or necessitate treatment, some patients with immunoglobulin-complexed enzyme disorders have previously been reported to have associated autoimmune diseases or malignant lesions. To address this issue, we reviewed the medical records of 42 patients in whom a macroenzyme had been detected during assessment at the Mayo Clinic between 1986 and 1990. Of these 42 patients, 21 had macro-creatine kinase, 10 had macro-lactate dehydrogenase, 6 had macro-aspartate aminotransferase, and 5 had macroamylase in the serum. Although the study group did not include all Mayo patients with this phenomenon, it represented a sufficient sample size to determine retrospectively whether specific dismissal diagnoses were present concurrently. The most common findings in this group of patients with macroenzymes were (1) advanced age (except for those with macro-aspartate aminotransferase), (2) cardiovascular disease (probably due to sampling bias), (3) malignant lesions (particularly in those with macro-creatine kinase), and (4) rheumatologic disease (in those with macro-lactate dehydrogenase). The immunoglobulin-complexed enzyme disorders are characterized by increased total serum enzyme levels that are often isolated and persistent. Physicians should be aware of the presence of macroenzymes so that invasive or costly procedures are not undertaken unnecessarily to determine the cause of increased serum enzyme levels.",
author = "Galasso, {P. J.} and Litin, {S. C.} and O'Brien, {J. F.}",
year = "1993",
language = "English (US)",
volume = "68",
pages = "349--354",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "4",

}

TY - JOUR

T1 - The macroenzymes

T2 - A clinical review

AU - Galasso, P. J.

AU - Litin, S. C.

AU - O'Brien, J. F.

PY - 1993

Y1 - 1993

N2 - Macroenzymes are serum enzymes that have a higher molecular mass than the corresponding enzyme normally found in serum under physiologic or pathophysiologic conditions. Although no evidence convincingly indicates that macroenzymes cause disease or necessitate treatment, some patients with immunoglobulin-complexed enzyme disorders have previously been reported to have associated autoimmune diseases or malignant lesions. To address this issue, we reviewed the medical records of 42 patients in whom a macroenzyme had been detected during assessment at the Mayo Clinic between 1986 and 1990. Of these 42 patients, 21 had macro-creatine kinase, 10 had macro-lactate dehydrogenase, 6 had macro-aspartate aminotransferase, and 5 had macroamylase in the serum. Although the study group did not include all Mayo patients with this phenomenon, it represented a sufficient sample size to determine retrospectively whether specific dismissal diagnoses were present concurrently. The most common findings in this group of patients with macroenzymes were (1) advanced age (except for those with macro-aspartate aminotransferase), (2) cardiovascular disease (probably due to sampling bias), (3) malignant lesions (particularly in those with macro-creatine kinase), and (4) rheumatologic disease (in those with macro-lactate dehydrogenase). The immunoglobulin-complexed enzyme disorders are characterized by increased total serum enzyme levels that are often isolated and persistent. Physicians should be aware of the presence of macroenzymes so that invasive or costly procedures are not undertaken unnecessarily to determine the cause of increased serum enzyme levels.

AB - Macroenzymes are serum enzymes that have a higher molecular mass than the corresponding enzyme normally found in serum under physiologic or pathophysiologic conditions. Although no evidence convincingly indicates that macroenzymes cause disease or necessitate treatment, some patients with immunoglobulin-complexed enzyme disorders have previously been reported to have associated autoimmune diseases or malignant lesions. To address this issue, we reviewed the medical records of 42 patients in whom a macroenzyme had been detected during assessment at the Mayo Clinic between 1986 and 1990. Of these 42 patients, 21 had macro-creatine kinase, 10 had macro-lactate dehydrogenase, 6 had macro-aspartate aminotransferase, and 5 had macroamylase in the serum. Although the study group did not include all Mayo patients with this phenomenon, it represented a sufficient sample size to determine retrospectively whether specific dismissal diagnoses were present concurrently. The most common findings in this group of patients with macroenzymes were (1) advanced age (except for those with macro-aspartate aminotransferase), (2) cardiovascular disease (probably due to sampling bias), (3) malignant lesions (particularly in those with macro-creatine kinase), and (4) rheumatologic disease (in those with macro-lactate dehydrogenase). The immunoglobulin-complexed enzyme disorders are characterized by increased total serum enzyme levels that are often isolated and persistent. Physicians should be aware of the presence of macroenzymes so that invasive or costly procedures are not undertaken unnecessarily to determine the cause of increased serum enzyme levels.

UR - http://www.scopus.com/inward/record.url?scp=0027450883&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027450883&partnerID=8YFLogxK

M3 - Article

C2 - 7681133

AN - SCOPUS:0027450883

VL - 68

SP - 349

EP - 354

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 4

ER -